Citations

Clear

4799 citation(s) found for "Yu, Jennifer".

No Increased Mercury Release from Dental Restorations at 1.5T, 3T, or 7T MRI
Burkett, Brian J. , Rasmussen, Chad M. , Fillmore, W. Jonathan , McDonald, Robert J. , Fagan, Andrew , Erdahl, Sarah A , Eckdahl, Steven J., Welker, Kirk M. , Fagan, Andrew J , Burkett, Brian , McDonald, Jennifer S.

Mayo Clinic

Magnetic Resonance in Medicine | September 27, 2023 | Volume: 91 | Issue: 2 | Pages: 660-669

10.1002/mrm.29872 | PMID 37755142 Get It

AbstractPurposeDental amalgam contains mercury and is commonly used in dental restorations. The impact of MRI on mercury excretion from dental amalgam is not well understood across clinical field strengths, especially 7T. We investigated the effects of MRI exposure on mercury excretion using fresh, lab‐created dental amalgam restorations and in extracted teeth with old, pre‐existing restorations.MethodsDonated, unfilled human teeth (n = 120) were restored with amalgam before being stored in saline, artificial saliva, or a dry box prior to MRI scanning. The teeth were placed in individual tubes of fresh artificial saliva and scanned at 1.5T, 3T, or 7T or left unscanned as controls. Mercury concentrations were measured 24–30 h later. Donated teeth with pre‐existing restorations (n = 40) were stored in artificial saliva, scanned at 7T or left unscanned as controls, and mercury concentration tested.ResultsFor teeth extracted and restored in a laboratory, no significant difference was found (F = 2.42, P = 0.072) between mean mercury concentrations of unscanned teeth (13.72 μg/L) and teeth scanned at 1.5T (10.88 μg/L), 3T (12.65 μg/L), or 7T (8.88 μg/L). For teeth extracted with previously placed restorations, no significant difference (P = 0.288) was found between unscanned controls (4.28 μg/L) and teeth scanned at 7T (6.63 μg/L).ConclusionMRI of dental amalgam does not significantly increase mercury excretion at 1.5T, 3T, or 7T compared to unscanned teeth. This holds true for controlled laboratory restorations as well as for those placed and lived with prior to extraction and scanning, demonstrating no added risk to the clinical patient or research subject.
The impact of teleneonatology on the Transport Risk Index of Physiologic Stability score for outborn neonates: A prospective, observational study
Patel, Rahul , Kreofsky, Beth L. , Hentz, Roland, Fang, Jennifer L. , Patel, Rahul K , Hentz, Roland C

Mayo Clinic

Journal of Telemedicine and Telecare | September 27, 2023 | Volume: 31 | Issue: 3 | Pages: 398-407

10.1177/1357633x231196334 | PMID 37753610 Get It

Introduction Teleneonatology (TN) allows neonatologists to use real-time, audio–video telemedicine to manage critically ill neonates located in community hospitals (CHs). The California Transport Risk Index of Physiologic Stability (Ca-TRIPS) score is a validated metric that predicts the risk of 7-day mortality for neonates undergoing medical transport. We hypothesized that neonates born in CHs who received TN consults would have lower (better) Ca-TRIPS scores upon arrival of the transport team than those who did not. Methods Neonates born in CHs between 8 December 2018 and 31 July 2022 who were transported to the neonatal intensive care unit were screened for eligibility. TN was available at 50% (12/24) of CHs, where care teams decided when to activate the service. Study data were abstracted from the electronic health record and used to calculate Ca-TRIPS scores. Scores were evaluated using zero-inflated negative binomial regression. Results Forty-two percent (161/385) of neonates received a TN consult. Neonates that received TN had lower birth weight, gestational age, and Apgar scores and were more often admitted with respiratory distress syndrome and respiratory failure. Neonates who received TN were less likely to have a Ca-TRIPS score of zero (odds ratio 0.51; 95% confidence interval 0.33, 0.78). When adjusted for baseline characteristics, this difference was no longer significant. Non-zero Ca-TRIPS scores were not different between groups. Discussion In this observational study, neonates that received TN did not have lower (better) Ca-TRIPS scores. Findings may be limited by confounding bias given between-group differences in baseline patient characteristics. Randomized studies are needed to determine whether TN impacts the physiologic stability of neonates requiring medical transport.
P20 Determining Clinically Meaningful Difference in Baseline EncephalApp Stroop Values to Predict HE-Related Outcomes With Multi-Center Validation
Badal, Bryan, Kanagalingam, Gowthami , Fagan, Andrew , Reddy, K. Rajender , O’Leary, Jacqueline G. , Kamath, Patrick S. , García–Tsao, Guadalupe , Biggins, Scott W. , Acharya, Chathur , Bajaj, Jasmohan S. , Badal, Bryan D. , Park, Dan M. , Lai, Jennifer C. , Tandon, Puneeta , Wong, Florence , Vargas, Hugo E.

Mayo Clinic

American Journal of Gastroenterology | September 26, 2023 | Volume: 118 | Issue: 9S | Pages: S14-S15

10.14309/01.ajg.0000948364.18197.db Get It

Nutrition Knowledge Of Firefighters
Nolte, Charles, Luedke, Joel, Erickson, Jacob L. , Zeller, Annette, Dobbs, Ward C. , Markert, Adam, Fields, Jennifer B. , Jones, Margaret T. , Zeller, Annette, Almonroeder, Thomas Gus , Jagim, Andrew R.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 471-471

10.1249/01.mss.0000984204.55589.9c Get It

Major Publications in the Critical Care Pharmacotherapy Literature: 2022
Gurnani, Payal K. , Barlow, Brooke , Busse, Laurence W. , Ford, Jenna , Gibson, Gabrielle , Lee, Jennifer , Rivosecchi, Ryan , Spezzano, Katherine , Thornton, Nathan, Vallabhajosyula, Saraschandra , Wieruszewski, Patrick M. , Vallabhajosyula, Saraschandra , Wieruszewski, Patrick M , Boling, Bryan , Díaz‐Gómez, José L. , Khanna, Ashish K. , Thornton, Nathan, Witenko, Corey J.

Mayo Clinic

Critical Care Explorations | September 25, 2023 | Volume: 5 | Issue: 10 | Pages: e0981

10.1097/cce.0000000000000981 | PMID 37753239 Get It

OBJECTIVES: A number of trials related to critical care pharmacotherapy were published in 2022. We aimed to summarize the most influential publications related to the pharmacotherapeutic care of critically ill patients in 2022. DATA SOURCES: PubMed/Medical Literature Analysis and Retrieval System Online and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update. STUDY SELECTION: Randomized controlled trials, prospective studies, or systematic review/meta-analyses of adult critically ill patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2022, and December 31, 2022, were included in this article. DATA EXTRACTION: Articles from a systematic search and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update were included and stratified into clinical domains based upon consistent themes. Consensus was obtained on the most influential publication within each clinical domain utilizing an a priori defined three-round modified Delphi process with the following considerations: 1) overall contribution to scientific knowledge and 2) novelty to the literature. DATA SYNTHESIS: The systematic search and Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update yielded a total of 704 articles, of which 660 were excluded. The remaining 44 articles were stratified into the following clinical domains: emergency/neurology, cardiovascular, gastroenterology/fluids/nutrition, hematology, infectious diseases/immunomodulation, and endocrine/metabolic. The final article selected from each clinical domain was summarized following a three-round modified Delphi process and included three randomized controlled trials and three systematic review/meta-analyses. Article topics summarized included dexmedetomidine versus other sedatives during mechanical ventilation, beta-blocker treatment in the critically ill, restriction of IV fluids in septic shock, venous thromboembolism prophylaxis in critically ill adults, duration of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia, and low-dose methylprednisolone treatment in severe community-acquired pneumonia. CONCLUSIONS: This concise review provides a perspective on articles published in 2022 that are relevant to the pharmacotherapeutic care of critically ill patients and their potential impact on clinical practice.
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
Qualls, David , Lambert, Nicholas , Caimi, Paolo F. , Merrill, Mwanasha H. , Pullarkat, Priyanka, Bond, David A. , Wehmeyer, Graham T. , Romancik, Jason T. , Amoozgar, Behzad , Leslie, Lori A. , Crombie, Jennifer L. , Khurana, Arushi , Nowakowski, Grzegorz S. , Maddocks, Kami J. , Rutherford, Sarah C. , Okwali, Michelle, Seshan, Venkatraman , Batlevi, Connie Lee , Qualls, David A , Merrill, Mwanasha , Bond, David A , Wehmeyer, Graham T , Romancik, Jason T , Nastoupil, Loretta J , Crombie, Jennifer L , Abramson, Jeremy S , Buege, Michael J , Seshan, Venkatraman , Batlevi, Connie L , Salles, Gilles A , Caimi, Paolo F , Godby, Richard , Nastoupil, Loretta J. , Abramson, Jeremy S. , Kahl, Brad S. , Buege, Michael J. , Salles, Gilles

Mayo Clinic

Blood | September 22, 2023 | Volume: 142 | Issue: 26 | Pages: 2327-2331

10.1182/blood.2023021274 | PMID 37738563 Get It

Abstract In this real-world evaluation of tafasitamab-lenalidomide (TL) in relapsed or refractory LBCL, patients receiving TL had higher rates of comorbidities and high-risk disease characteristics, and substantially lower progression-free survival and overall survival, compared with the L-MIND registration clinical trial for TL.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions
Wang, Minggui , Ge, Lizhao , Chen, Liang , Komarow, Lauren , Hanson, Blake , Cober, Eric , Alenazi, Thamer H. , Xie, Qing , Liu, Zhengyin , Li, Lanjuan , Yu, Yunsong , Gao, Hainv , Figueroa, Jairo, Herc, Erica , Córdova, Ezequiel , Weston, Gregory , Kaye, Keith S. , Dhar, Sorabh , Munita, José M. , Salata, Robert A. , Vilchez, Samuel, Stryjewski, Martín E. , Iovleva, Alina , Evans, Scott , Baum, Keri, Hill, Carol , Kreiswirth, Barry N. , Patel, Robin , Arias, Cesar A, Chambers, Henry F. , Fowler, Vance G. , Satlin, Michael J. , Investigators, Multi-Drug Resistant Organism Network, Zhang, Fujie , Castelnuovo, Valentina Di, Gutierrez, Jose Millan Oñate, Evans, Beth , Cross, H. R. , Arias, Rebekka M. , Fowler, Vance G, Ordóñez, Karen , Li, Linghua , Kreiswirth, Barry N , Desai, Samit, Rioseco, María Luisa, Vilchez, Samuel, Sánchez, Marisa , Valderrama, Sandra , Figueroa, Jairo, Arias, Cesar A, Dinh, An Q , Panesso, Diane, Rydell, Kirsten, Tran, Truc T. , Jiang, Jianping , Xu, Xiaogang , Spencer, María, Marshall, Steven H. , Rudin, Susan D., Greenwood-Quaintance, Kerry, Schmidt-Malan, Suzannah M., Revolinski, Sara , Wortmann, Glenn , Kalayjian, Robert C. , Ostrowsky, Belinda , Patel, Gopi , Eiras, Daniel , Garcia-Diaz, Julia, Farrell, John J. , Paterson, David L, Kaye, Keith S, Waters, Mary Jo, Eilertson, Brandon , Ng, Oon Tek , De, Partha Pratim, Chew, Kean Lee , Smitasin, Nares , Gallagher, Jason C , Leroi, Marcel , McCarty, Todd P , Lautenbach, Ebbing , Hanson, Blake, Perez, Federico, Banerjee, Ritu , Dhar, Sorabh, Westblade, Lars F. , Yu, Yunsong , Cordova, Ezequiel , Kaye, Keith S , Evans, Scott R , Patel, Robin , van Duin, David , Pérez, Federico , Jiang, Jianping , Chen, Liang , Wang, Minggui , Munita, Jose M , Reyes, Jinnethe , Zong, Zhiyong , Kanj, Souha S. , Tambyah, Paul Anantharajah , Garcia‐Diaz, Julia , Villegas, María Virginia , Kreiswirth, Barry N , Paterson, David L. , Arias, Cesar A, Bonomo, Robert A. , Fowler, Vance G. , Doi, Yohei , Investigators, Multi-Drug Resistant Organism Network, Lok, Judith J. , Richter, Susan, Anderson, Deverick J. , Evans, Beth, Cross, Heather R, Fowler, Vance G, Jacob, Jesse T. , Manca, Claudia , Vilchez, Samuel, Figueroa, Jairo, Arias, Cesar A, Hu, Fupin , Su, Jiachun , Wang, Minggui, Xu, Xiaogang, Yang, Yang, Huskins, W. Charles , Greenwood‐Quaintance, Kerryl E. , Kim, Angela , Garcia-Diaz, Julia, Salcedo, Soraya , Henderson, Andrew , Paterson, David L, Kaye, Keith S, Fries, Bettina C. , Marimuthu, Kalisvar , Peleg, Anton Yariv , Xiao, Yonghong , Garner, Omai B. , Abbo, Lilian M. , Han, Jennifer , Wong, Darren , Hanson, Blake, Díaz, Lorena

Mayo Clinic

Clinical Infectious Diseases | September 22, 2023 | Volume: 78 | Issue: 2 | Pages: 248-258

10.1093/cid/ciad556 | PMID 37738153 Get It

Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAb) is 1 of the most problematic antimicrobial-resistant bacteria. We sought to elucidate the international epidemiology and clinical impact of CRAb. Methods In a prospective observational cohort study, 842 hospitalized patients with a clinical CRAb culture were enrolled at 46 hospitals in five global regions between 2017 and 2019. The primary outcome was all-cause mortality at 30 days from the index culture. The strains underwent whole-genome analysis. Results Of 842 cases, 536 (64%) represented infection. By 30 days, 128 (24%) of the infected patients died, ranging from 1 (6%) of 18 in Australia-Singapore to 54 (25%) of 216 in the United States and 24 (49%) of 49 in South-Central America, whereas 42 (14%) of non-infected patients died. Bacteremia was associated with a higher risk of death compared with other types of infection (40 [42%] of 96 vs 88 [20%] of 440). In a multivariable logistic regression analysis, bloodstream infection and higher age-adjusted Charlson comorbidity index were independently associated with 30-day mortality. Clonal group 2 (CG2) strains predominated except in South-Central America, ranging from 216 (59%) of 369 in the United States to 282 (97%) of 291 in China. Acquired carbapenemase genes were carried by 769 (91%) of the 842 isolates. CG2 strains were significantly associated with higher levels of meropenem resistance, yet non-CG2 cases were over-represented among the deaths compared with CG2 cases. Conclusions CRAb infection types and clinical outcomes differed significantly across regions. Although CG2 strains remained predominant, non-CG2 strains were associated with higher mortality. Clinical Trials Registration. NCT03646227.
Recommendations for Centers Performing Pediatric Heart Surgery in the United States
Backer, Carl L., Overman, David M. , Romano, Jennifer C., Tweddell, James S., Marino, Bradley S. , Bacha, Emile , Jaquiss, Robert, Zaidi, Ali N. , Gurvitz, Michelle , Costello, John M. , Pierick, Trudy A. , Ravekes, William, Reagor, James A. , Spaeth, James P., Mahle, William T. , Shin, Andrew Y. , Karamlou, Tara , Welke, Karl F. , Bryant, Roosevelt , Husain, S. Adil , Chen, Jonathan M., Wells, Winfield J., Glatz, Andrew C. , McElhinney, Doff B. , Parra, David , Pasquali, Sara K. , McElhinney, Doff B , Dearani, Joseph A. , Kumar, S. Ram , Jaquiss, Robert D.B. , Louis, James D. St. , Lopez, Keila N. , Kaza, Aditya K.

Mayo Clinic

World Journal for Pediatric and Congenital Heart Surgery | September 22, 2023 | Volume: 14 | Issue: 5 | Pages: 642-679

10.1177/21501351231190353 | PMID 37737602 Get It

Care and outcomes for the more than 40,000 patients undergoing pediatric and congenital heart surgery in the United States annually are known to vary widely. While consensus recommendations have been published across numerous fields as one mechanism to promote a high level of care delivery across centers, it has been more than two decades since the last pediatric heart surgery recommendations were published in the United States. More recent guidance is lacking, and collaborative efforts involving the many disciplines engaged in caring for these children have not been undertaken to date. The present initiative brings together professional societies spanning numerous care domains and congenital cardiac surgeons, pediatric cardiologists, nursing, and other healthcare professionals from diverse programs around the country to develop consensus recommendations for United States centers. The focus of this initial work is on pediatric heart surgery, and it is recommended that future efforts focus in detail on the adult congenital population. We describe the background, rationale, and methodology related to this collaborative effort, and recommendations put forth for Essential Care Centers (essential services necessary for any program), and Comprehensive Care Centers (services to optimize comprehensive and high-complexity care), encompassing structure, process, and outcome metrics across 14 domains.
Lessons Learned and Practice Pearls: Optimal Integration of Electronic Patient-Reported Outcomes in the Medical Oncology Clinic
O’Sullivan, Ciara C. , Cracchiolo, Jennifer R. , Tevaarwerk, Amyé , Tevaarwerk, Amye J

Mayo Clinic

JCO Oncology Practice | September 21, 2023 | Volume: 19 | Issue: 11 | Pages: 951-954

10.1200/op.23.00415 | PMID 37733976 Get It

This editorial reviews the many opportunities and obstacles associated with ePRO integration in oncology
Meeting Report: 11th and 12th Annual Meetings of the Society of Anesthesia and Sleep Medicine: Taking Sleep Health Into the Next Decade
Pappu, Ameya , Ramachandran, Satya Krishna , Auckley, Dennis , Won, Christine , Gali, Bhargavi , Hargett, Mary J. , Nafiu, Olubukola O. , Dominguez, Jennifer E. , Singh, Mandeep

Mayo Clinic

Anesthesia & Analgesia | September 21, 2023 | Volume: 137 | Issue: 6 | Pages: e45-e48

10.1213/ane.0000000000006632 | PMID 40009003 Get It